Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:FWP

Forward Pharma A/S (FWP) Stock Price, News & Analysis

Forward Pharma A/S logo

About Forward Pharma A/S Stock (NASDAQ:FWP)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$1.95
$1.95
50-Day Range
$1.79
$3.19
52-Week Range
$1.50
$6.48
Volume
N/A
Average Volume
7,484 shs
Market Capitalization
$13.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Remove Ads
Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

The Same Setup That Led to a 131% Gold Surge Is Happening Now
Historically, when confidence in credit markets gets too high, a gold acceleration phase follows… And we’re seeing the same setup playing out again… With central banks piling into gold, inflation lingering, and debt levels soaring, I believe we’re on the verge of another Gold acceleration cycle—and it could happen fast. Back in November, I told folks to “buy the dip” in gold and I sure hope they listened… I cannot promise future returns or against losses, but now I’m giving you another heads-up… I broke down exactly what I am seeing and how anyone with a regular brokerage account can take advantage… Without actually holding any gold…
Firebrick Pharma’s Strategic Moves Boost Market Position
See More Headlines

FWP Stock Analysis - Frequently Asked Questions

Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.06.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Akari Therapeutics (AKTX), Aldeyra Therapeutics (ALDX) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
9/01/2016
Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FWP
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$10.09 per share
Price / Book
0.19

Miscellaneous

Free Float
2,023,000
Market Cap
$13.83 million
Optionable
Not Optionable
Beta
1.38

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:FWP) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners